John P. Longenecker Phd serves as Executive at FAVRILLE INC, where they oversee executive responsibilities. Since joining the company, John P. Longenecker Phd has executed 42 insider transactions totaling $2.0M, demonstrating a bearish approach to their equity position. Their most recent transaction on Mar 3, 2022 involved selling 7,000 shares valued at $502.2K.
John P. Longenecker Phd currently holds 18,823 shares of FAVRILLE INC (FVRL), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, John P. Longenecker Phd has been a net seller of FVRL stock. They have purchased $44.5K and sold $1.9M worth of shares.
John P. Longenecker Phd's most recent insider trade was on Mar 3, 2022, when they sold 7,000 shares at $71.74 per share.
Get notified when new Form 4 filings are submitted
| $10.81 |
| Discretionary |
| Jun 9, 2021 | PCRX | $0 | Award | 1,066 | $N/A | Discretionary |
| Mar 1, 2021 | PCRX | $361.3K | Sale | 5,000 | $72.26 | Discretionary |
| Mar 1, 2021 | PCRX | $69.9K | Option Exercise | 5,000 | $13.98 | Discretionary |
| Jun 9, 2020 | PCRX | $0 | Award | 1,260 | $N/A | Discretionary |
| Mar 12, 2020 | PCRX | $6.0K | Option Exercise | 3,736 | $1.61 | Discretionary |
| Dec 2, 2019 | PCRX | $1.4K | Option Exercise | 872 | $1.61 | Discretionary |
| Dec 2, 2019 | PCRX | $5.0K | Option Exercise | 3,128 | $1.61 | Discretionary |
| Dec 2, 2019 | PCRX | $60.0K | Sale | 1,300 | $46.13 | Discretionary |
| Jun 5, 2019 | PCRX | $0 | Award | 4,134 | $N/A | Discretionary |
| Aug 10, 2018 | ALRN | $24.5K | Purchase | 10,000 | $2.45 | Discretionary |
| Jun 13, 2018 | PCRX | $0 | Award | 782 | $N/A | Discretionary |
| Jun 14, 2017 | PCRX | $0 | Award | 1,357 | $N/A | Discretionary |
| Jun 15, 2016 | PCRX | $0 | Award | 1,488 | $N/A | Discretionary |
| Jan 12, 2016 | PCRX | $20.0K | Purchase | 300 | $66.55 | Discretionary |
| Jun 3, 2015 | PCRX | $0 | Award | 2,000 | $N/A | Discretionary |
| Mar 12, 2015 | PCRX | $89.7K | Option Exercise | 3,000 | $29.90 | Discretionary |
| Mar 12, 2015 | PCRX | $285.8K | Sale | 3,000 | $95.28 | Discretionary |
| Dec 29, 2014 | PCRX | $93.3K | Sale | 1,000 | $93.32 | Discretionary |
| Dec 29, 2014 | PCRX | $29.9K | Option Exercise | 1,000 | $29.90 | Discretionary |
| Sep 29, 2014 | PCRX | $96.4K | Sale | 1,000 | $96.40 | Discretionary |
| Sep 29, 2014 | PCRX | $29.9K | Option Exercise | 1,000 | $29.90 | Discretionary |
| Jun 30, 2014 | PCRX | $29.9K | Option Exercise | 1,000 | $29.90 | Discretionary |
| Jun 30, 2014 | PCRX | $91.6K | Sale | 1,000 | $91.60 | Discretionary |
| Mar 28, 2014 | PCRX | $64.6K | Sale | 1,000 | $64.63 | Discretionary |
| Mar 28, 2014 | PCRX | $29.9K | Option Exercise | 1,000 | $29.90 | Discretionary |
| Dec 30, 2013 | PCRX | $924 | Option Exercise | 574 | $1.61 | Discretionary |
| Dec 30, 2013 | PCRX | $935 | Option Exercise | 581 | $1.61 | Discretionary |
| Dec 30, 2013 | PCRX | $2.2K | Option Exercise | 1,345 | $1.61 | Discretionary |